BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35032570)

  • 1. Preclinical frailty assessments: Phenotype and frailty index identify frailty in different mice and are variably affected by chronic medications.
    Mach J; Allore H; Gnjidic D; Gemikonakli G; Kane AE; Howlett SE; de Cabo R; Le Couteur D; Hilmer SN
    Exp Gerontol; 2022 May; 161():111700. PubMed ID: 35032570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Polypharmacy with Increasing Drug Burden Index Exacerbates Frailty and Impairs Physical Function, with Effects Attenuated by Deprescribing, in Aged Mice.
    Mach J; Gemikonakli G; Logan C; Vander Wyk B; Allore H; Ekambareshwar S; Kane AE; Howlett SE; de Cabo R; Le Couteur DG; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):1010-1018. PubMed ID: 32147704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study.
    Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T
    Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.
    O'Connell J; Henman MC; McMahon N; Burke É; McCallion P; McCarron M; O'Dwyer M
    Pharmacoepidemiol Drug Saf; 2020 Apr; 29(4):482-492. PubMed ID: 32134549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk prescribing and incidence of frailty among older community-dwelling men.
    Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Cumming RG; Handelsman DJ; McLachlan AJ; Abernethy DR; Banks E; Le Couteur DG
    Clin Pharmacol Ther; 2012 Mar; 91(3):521-8. PubMed ID: 22297385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication Assessment in an Older Population during Acute Care Hospitalization and Its Effect on the Anticholinergic Burden: A Prospective Cohort Study.
    Espaulella-Ferrer M; Molist-Brunet N; Espaulella-Panicot J; Sevilla-Sánchez D; Puigoriol-Juvanteny E; Otero-Viñas M
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of medications and polypharmacy are associated with frailty in older adults: results from the Midlife in the United States study.
    Alqahtani B
    Front Public Health; 2023; 11():1148671. PubMed ID: 37304087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians.
    Harris DA; Guo Y; Nakhla N; Tadrous M; Hogan DB; Hennessy D; Langlois K; Garner R; Leslie S; Bronskill SE; Heckman G; Maxwell CJ
    Health Rep; 2022 Jun; 33(6):3-16. PubMed ID: 35876612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
    Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S
    J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing.
    Gemikonakli G; Mach J; Zhang F; Bullock M; Tran T; El-Omar E; Hilmer SN
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):213-222. PubMed ID: 36124741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial.
    Jamieson H; Nishtala PS; Bergler HU; Weaver SK; Pickering JW; Ailabouni NJ; Abey-Nesbit R; Gullery C; Deely J; Gee SB; Hilmer SN; Mangin D
    J Gerontol A Biol Sci Med Sci; 2023 Aug; 78(9):1692-1700. PubMed ID: 36692224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoping Review of Studies Evaluating Frailty and Its Association with Medication Harm.
    Lam JYJ; Barras M; Scott IA; Long D; Shafiee Hanjani L; Falconer N
    Drugs Aging; 2022 May; 39(5):333-353. PubMed ID: 35597861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypharmacy at discharge in older hospitalised patients in Vietnam and its association with frailty.
    Nguyen TX; Nguyen TN; Nguyen AT; Nguyen HTT; Nguyen TTH; Nguyen TN; Pham T; Vu HTT
    Australas J Ageing; 2020 Sep; 39(3):230-236. PubMed ID: 31677221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy Is Significantly and Positively Associated with the Frailty Status Assessed Using the 5-Item FRAIL Scale, Cardiovascular Health Phenotypic Classification of Frailty Index, and Study of Osteoporotic Fractures Scale.
    Hung CD; Yang CC; Lee CY; Hu SC; Chen SC; Hung CH; Chuang HY; Chen CY; Kuo CH
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy is associated with frailty in Japanese community-dwelling older adults.
    Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
    Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study.
    Jamsen KM; Bell JS; Hilmer SN; Kirkpatrick CM; Ilomäki J; Le Couteur D; Blyth FM; Handelsman DJ; Waite L; Naganathan V; Cumming RG; Gnjidic D
    J Am Geriatr Soc; 2016 Jan; 64(1):89-95. PubMed ID: 26782856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals.
    Ekram ARMS; Woods RL; Ryan J; Espinoza SE; Gilmartin-Thomas JFM; Shah RC; Mehta R; Kochar B; Lowthian JA; Lockery J; Orchard S; Nelson M; Fravel MA; Liew D; Ernst ME
    Arch Gerontol Geriatr; 2022; 101():104694. PubMed ID: 35349875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effects of Frailty and Polypharmacy on Health Outcomes in Older Adults: Frailty Outweighs Polypharmacy.
    Chen YZ; Huang ST; Wen YW; Chen LK; Hsiao FY
    J Am Med Dir Assoc; 2021 Mar; 22(3):606.e7-606.e18. PubMed ID: 32873474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frailty prevalence using Frailty Index, associated factors and level of agreement among frailty tools in a cohort of Japanese older adults.
    Arakawa Martins B; Visvanathan R; Barrie H; Huang CH; Matsushita E; Okada K; Satake S; Uno C; Kuzuya M
    Arch Gerontol Geriatr; 2019; 84():103908. PubMed ID: 31319367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.